ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is 10.83.
Share Price | ₹1,301.9 | Jan 09,2025 |
Market Cap | ₹742.1 Cr | |
Earnings-TTM | ₹68.5 Cr | TTM-Standalone Results |
Price/Earnings | 10.83x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹742.1 Cr] as on Jan 09,2025
(/) Earnings [ ₹68.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 10.83x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay 10.83 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.82x.
- ALBERT DAVID 's operated at median p/e ratio of 8.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2021 at 9.71x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 8.08x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALBERT DAVID | 68.55 | 10.83 | 742.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.34 | 438,143.0 |
CIPLA LTD | 4,485.22 | 26.80 | 120,185.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 21.17 | 114,450.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 23.63 | 101,569.0 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.19 | 154,578.0 |
MANKIND PHARMA LTD | 2,124.86 | 54.93 | 116,709.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 62.41 | 112,462.0 |
LUPIN LTD | 2,651.94 | 38.74 | 102,735.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.15 | 72,524.7 |
ABBOTT INDIA LTD | 1,284.66 | 49.22 | 63,232.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 10.83x |
Max industry PE | 84.19x |
Median industry PE | 38.74x |
Average industry PE | 39.22x |
You may also like the below Video Courses